Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Von Eschenbach: Former FDA commissioner Andrew von Eschenbach will split his time between MD Anderson and the regulatory consulting firm Greenleaf Health LLC, which he will join as senior advisor. He returns to the University of Texas MD Anderson Cancer Center in Houston as an adjunct professor and will also serve on the advisory board of the David Koch Center for Applied Research in Genitourinary Cancers. On the policy side, von Eschenbach says he will use Greenleaf Health as a "launching pad" to participate in the discussion of macro health issues like personalized medicine, genomics and informatics. Von Eschenbach resigned as FDA commissioner upon the inauguration of President Obama; his successor has not yet been named

You may also be interested in...



People In Brief

The latest moves by movers and shakers in the medical device and diagnostics industries

People In Brief

Schultz the consultant: Former CDRH Director Daniel Schultz has joined Greenleaf Health as senior VP for medical devices and combination products, the consulting firm announced Jan. 6. Schultz left the device center in August as the new FDA leadership reassessed past CDRH device review practices, which have come under intensifying public criticism (1"The Gray Sheet" Aug. 17, 2009). He had led the center for five years and worked at CDRH for 15 years. Greenleaf is developing into a regular landing spot for recently departed top FDA officials. Taryn Fritz Warpole, former deputy chief of staff, joined the firm in July and former Commissioner Andrew von Eschenbach signed on as a senior advisor in March (2"The Gray Sheet" March 9, 2009). Former FDA Chief of Staff Patrick Ronan founded the consulting practice

People In Brief

Schultz the consultant: Former CDRH Director Daniel Schultz has joined Greenleaf Health as senior VP for medical devices and combination products, the consulting firm announced Jan. 6. Schultz left the device center in August as the new FDA leadership reassessed past CDRH device review practices, which have come under intensifying public criticism (1"The Gray Sheet" Aug. 17, 2009). He had led the center for five years and worked at CDRH for 15 years. Greenleaf is developing into a regular landing spot for recently departed top FDA officials. Taryn Fritz Warpole, former deputy chief of staff, joined the firm in July and former Commissioner Andrew von Eschenbach signed on as a senior advisor in March (2"The Gray Sheet" March 9, 2009). Former FDA Chief of Staff Patrick Ronan founded the consulting practice

Related Content

Topics

UsernamePublicRestriction

Register

MT027193

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel